by admin | Nov 25, 2019 | Funding
Azeria Therapeutics, a newly formed pioneer factor drug discovery company, announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund. Azeria was originally founded in 2017 by Sixth Element...
by admin | Nov 18, 2019 | Funding
LUNAC Therapeutics has spun out of the University of Leeds with €3.09M of funding from the university and the VC firm Epidarex Capital for the development of anticoagulants with a lower risk for bleeding than those currently available. The new anticoagulants will...
by admin | Nov 18, 2019 | Funding
Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round of $7M. The financing round was led by a group of US, Europe and Israel-based private investors; most of the investment...
by admin | Nov 11, 2019 | Funding
Two of the largest drugmakers in the country are investing in a startup applying artificial intelligence in pathology. Boston-based PathAI said that it had closed its $75 million Series B financing round with funding from New York-based Bristol-Myers Squibb and the...
by admin | Nov 4, 2019 | Funding
The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs. A startup that aims to provide a software-as-a-service platform to allow genomic...
